Literature DB >> 32288276

Viral cysteine proteinases.

Alexander E Gorbalenya1,2, Eric J Snijder3.   

Abstract

Dozens of novel cysteine proteinases have been identified in positive single-stranded RNA viruses and, for the first time, in large double-stranded DNA viruses. The majority of these proteins are distantly related to papain or chymotrypsin and may be direct descendants of primordial proteolytic enzymes. Virus genome synthesis and expression, virion formation, virion entry into the host cell, as well as cellular architecture and functioning can be under the control of viral cysteine proteinases during infection. RNA virus proteinases mediate their liberation from giant multidomain precursors in which they tend to occupy conserved positions. These proteinases possess a narrow substrate specificity, can cleave in cis and in trans, and may also have additional, nonproteolytic functions. The mechanisms of catalysis, substrate recognition and RNA binding were highlighted by the recent analysis of the three-dimensional structure of the chymotrypsin-like cysteine proteinases of two RNA viruses. © ESCOM Science Publishers B.V 1996.

Entities:  

Keywords:  Chymotrypsin; Cysteine Proteinase; Papain; Substrate Recognition; Virion Entry

Year:  1996        PMID: 32288276      PMCID: PMC7104566          DOI: 10.1007/BF02174046

Source DB:  PubMed          Journal:  Perspect Drug Discov Des        ISSN: 0928-2866


  179 in total

Review 1.  Proteolytic processing of picornaviral polyprotein.

Authors:  A C Palmenberg
Journal:  Annu Rev Microbiol       Date:  1990       Impact factor: 15.500

Review 2.  Adenovirus endopeptidase and its role in virus infection.

Authors:  J M Weber
Journal:  Curr Top Microbiol Immunol       Date:  1995       Impact factor: 4.291

3.  Expression and purification of a recombinant tobacco etch virus NIa proteinase: biochemical analyses of the full-length and a naturally occurring truncated proteinase form.

Authors:  T D Parks; E D Howard; T J Wolpert; D J Arp; W G Dougherty
Journal:  Virology       Date:  1995-06-20       Impact factor: 3.616

4.  Hydrolysis of a series of synthetic peptide substrates by the human rhinovirus 14 3C proteinase, cloned and expressed in Escherichia coli.

Authors:  D C Orr; A C Long; J Kay; B M Dunn; J M Cameron
Journal:  J Gen Virol       Date:  1989-11       Impact factor: 3.891

5.  Viral cysteine proteases are homologous to the trypsin-like family of serine proteases: structural and functional implications.

Authors:  J F Bazan; R J Fletterick
Journal:  Proc Natl Acad Sci U S A       Date:  1988-11       Impact factor: 11.205

6.  Polyprotein processing in cis and in trans by hepatitis A virus 3C protease cloned and expressed in Escherichia coli.

Authors:  S A Harmon; W Updike; X Y Jia; D F Summers; E Ehrenfeld
Journal:  J Virol       Date:  1992-09       Impact factor: 5.103

7.  Characterization of a human coronavirus (strain 229E) 3C-like proteinase activity.

Authors:  J Ziebuhr; J Herold; S G Siddell
Journal:  J Virol       Date:  1995-07       Impact factor: 5.103

8.  The 2A proteinase of human rhinovirus is a zinc containing enzyme.

Authors:  W Sommergruber; G Casari; F Fessl; J Seipelt; T Skern
Journal:  Virology       Date:  1994-11-01       Impact factor: 3.616

9.  Cotranslational autoproteolysis involved in gene expression from a double-stranded RNA genetic element associated with hypovirulence of the chestnut blight fungus.

Authors:  G H Choi; R Shapira; D L Nuss
Journal:  Proc Natl Acad Sci U S A       Date:  1991-02-15       Impact factor: 11.205

10.  Nucleotide sequence of the human coronavirus 229E RNA polymerase locus.

Authors:  J Herold; T Raabe; B Schelle-Prinz; S G Siddell
Journal:  Virology       Date:  1993-08       Impact factor: 3.616

View more
  13 in total

1.  Molecular Interactions of Tannic Acid with Proteins Associated with SARS-CoV-2 Infectivity.

Authors:  Mohamed Haddad; Roger Gaudreault; Gabriel Sasseville; Phuong Trang Nguyen; Hannah Wiebe; Theo Van De Ven; Steve Bourgault; Normand Mousseau; Charles Ramassamy
Journal:  Int J Mol Sci       Date:  2022-02-27       Impact factor: 5.923

2.  Identification of Inhibitors of SARS-CoV-2 3CL-Pro Enzymatic Activity Using a Small Molecule in Vitro Repurposing Screen.

Authors:  Maria Kuzikov; Elisa Costanzi; Jeanette Reinshagen; Francesca Esposito; Laura Vangeel; Markus Wolf; Bernhard Ellinger; Carsten Claussen; Gerd Geisslinger; Angela Corona; Daniela Iaconis; Carmine Talarico; Candida Manelfi; Rolando Cannalire; Giulia Rossetti; Jonas Gossen; Simone Albani; Francesco Musiani; Katja Herzog; Yang Ye; Barbara Giabbai; Nicola Demitri; Dirk Jochmans; Steven De Jonghe; Jasper Rymenants; Vincenzo Summa; Enzo Tramontano; Andrea R Beccari; Pieter Leyssen; Paola Storici; Johan Neyts; Philip Gribbon; Andrea Zaliani
Journal:  ACS Pharmacol Transl Sci       Date:  2021-03-11

3.  Covalent narlaprevir- and boceprevir-derived hybrid inhibitors of SARS-CoV-2 main protease.

Authors:  Daniel W Kneller; Hui Li; Gwyndalyn Phillips; Kevin L Weiss; Qiu Zhang; Mark A Arnould; Colleen B Jonsson; Surekha Surendranathan; Jyothi Parvathareddy; Matthew P Blakeley; Leighton Coates; John M Louis; Peter V Bonnesen; Andrey Kovalevsky
Journal:  Nat Commun       Date:  2022-04-27       Impact factor: 17.694

Review 4.  Practical application of bioinformatics by the multidisciplinary VIZIER consortium.

Authors:  Alexander E Gorbalenya; Philippe Lieutaud; Mark R Harris; Bruno Coutard; Bruno Canard; Gerard J Kleywegt; Alexander A Kravchenko; Dmitry V Samborskiy; Igor A Sidorov; Andrey M Leontovich; T Alwyn Jones
Journal:  Antiviral Res       Date:  2010-02-11       Impact factor: 5.970

5.  LAMPA, LArge Multidomain Protein Annotator, and its application to RNA virus polyproteins.

Authors:  Anastasia A Gulyaeva; Andrey I Sigorskih; Elena S Ocheredko; Dmitry V Samborskiy; Alexander E Gorbalenya
Journal:  Bioinformatics       Date:  2020-05-01       Impact factor: 6.937

6.  Are vanadium complexes druggable against the main protease Mpro of SARS-CoV-2? - A computational approach.

Authors:  Thomas Scior; Hassan H Abdallah; Siti Fatimah Zaharah Mustafa; José Antonio Guevara-García; Dieter Rehder
Journal:  Inorganica Chim Acta       Date:  2021-02-11       Impact factor: 2.545

7.  Identification of 3-chymotrypsin like protease (3CLPro) inhibitors as potential anti-SARS-CoV-2 agents.

Authors:  Vicky Mody; Shashidharamurthy Taval; Joanna Ho; Savannah Wills; Ahmed Mawri; Latasha Lawson; Maximilian C C J C Ebert; Guillaume M Fortin; Srujana Rayalam
Journal:  Commun Biol       Date:  2021-01-20

8.  The autocatalytic release of a putative RNA virus transcription factor from its polyprotein precursor involves two paralogous papain-like proteases that cleave the same peptide bond.

Authors:  J Ziebuhr; V Thiel; A E Gorbalenya
Journal:  J Biol Chem       Date:  2001-06-28       Impact factor: 5.157

9.  A human RNA viral cysteine proteinase that depends upon a unique Zn2+-binding finger connecting the two domains of a papain-like fold .

Authors:  J Herold; S G Siddell; A E Gorbalenya
Journal:  J Biol Chem       Date:  1999-05-21       Impact factor: 5.157

10.  Covalent narlaprevir- and boceprevir-derived hybrid inhibitors of SARS-CoV-2 main protease: room-temperature X-ray and neutron crystallography, binding thermodynamics, and antiviral activity.

Authors:  Daniel Kneller; Hui Li; Gwyndalyn Phillips; Kevin Weiss; Qiu Zhang; Mark Arnould; Colleen Jonsson; Surekha Surendranathan; Jyothi Parvathareddy; Matthew Blakeley; Leighton Coates; John Louis; Peter Bonnesen; Andrey Kovalevsky
Journal:  Res Sq       Date:  2022-02-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.